Drugs / GP40141
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05652595 | Jun 2022 → Jun 2024 | — | Geropharm | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GP40141 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05652595 ↗ |
| Route | Subcutaneous | “Subcutaneously in the shoulder area” NCT05652595 ↗ |